Exploring Haloxylon articulatum: a Sustainable Source of Allosteric EGFR Inhibitors with Promising Anticancer Activity

Abstract Medicinal plants have long been recognized as reservoirs of bioactive compounds, and Haloxylon articulatum, a halophyte adapted to arid environments, has traditional medicinal relevance. In this study, we systematically investigated the chemical composition, antioxidant activity, and anticancer potential of...

miRNA-1231 Regulated EGFR Signaling: A Potential Therapeutic Target for Hepatocellular Carcinoma

Abstract Liver Cancer is the sixth leading cause of morbidity and mortality worldwide. Effective treatment for HCC is challenging and heavily depends on early diagnosis. There is urgent need to identify a potent therapeutic target for HCC. Among various signaling...

Radiomics-Based Gradient Boosting Model Predicts EGFR Expression and Therapy Response in High-Grade Glioma Using Contrast-Enhanced MRI

Radiomics-Based Gradient Boosting Model Predicts EGFR Expression and Therapy Response in High-Grade Glioma Using Contrast-Enhanced MRI A recent study published in the *Journal of Translational Medicine* has introduced a radiomics-based gradient boosting model that utilizes contrast-enhanced MRI to predict epidermal...

MICALL2 promotes angiogenesis of colorectal cancer by regulating the EGFR/PI3K/AKT/KLF5/VEGFA axis

AbstractColorectal cancer (CRC) is a common malignancy with high incidence and mortality, and tumor angiogenesis plays a crucial role in its progression and metastasis. Although anti-angiogenic therapies are promising, their effectiveness is limited by side effects, drug resistance, and relapse,...

Changes in EGFR activity following CRISPR/Cas9-editing of the EGF binding domain

Elevated Epidermal Growth Factor Receptor (EGFR) expression is observed in most cervical cancers, and it is frequently associated with poor clinical outcomes. The limited efficacy of existing EGFR-targeted therapies in cervical cancer highlights the need for a deeper understanding of...